Medical Health & Life Science Research News

New study: Hemodialysis and peritoneal dialysis market worth 83.89 billion USD by 2021

New study: Hemodialysis and peritoneal dialysis market worth 83.89 billion USD by 2021

The global peritoneal dialysis market is estimated to reach 83.89 Billion by 2021, at a CAGR of 6.0% from 2016 to 2021. The growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population, preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services. However, product recalls and the risks & complications associated with dialysis are restricting the growth of hemodialysis market to a certain extent. Moreover, high competition among market players, high procedural cost, and low cost of kidney transplantation are the foremost challenges faced by industry players.

- Advertising -

The report "Hemodialysis and Peritoneal Dialysis Market Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User (In-center, Hospital, Home) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 140 market data tables and 68 figures spread through 274 pages and in-depth TOC on “Hemodialysis and Peritoneal Dialysis Market Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User (In-center, Hospital, Home) - Global Forecast to 2021”
http://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html

This report studies the hemodialysis and peritoneal dialysis market over the forecast period of 2016 to 2021. The market is expected to reach USD 83.89 Billion by 2021, growing at a CAGR of 6.0% from 2016 to 2021.

- Advertising -

The global hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis. The hemodialysis (HD) products and services market includes machines, consumables, and services.

The peritoneal dialysis (PD) products and services market includes machines, concentrates/dialysates, catheters, transfer sets, and PD services. Furthermore, on the basis of end user, the global hemodialysis and peritoneal dialysis market has been segmented into in-center dialysis and home dialysis.

The growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population, preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services. However, a number of product recalls and the risks & complications associated with dialysis are restricting the growth of this market to a certain extent.

In 2016, North America (comprising the U.S. and Canada) is estimated to account for the largest share of the global hemodialysis and peritoneal dialysis market.

The large share of this region is attributed to several factors, such as its higher per capita income as compared to other regions, favorable reimbursement scenario, and huge demand for dialysis procedures. However, the Asia-Pacific dialysis market is expected to witness the highest growth in the forecast period.

Factors such as the presence of a large patient population base, increasing number of private and public owned dialysis centers, improving reimbursement and insurance scenario, and increasing government initiatives are propelling the growth of the dialysis market in the Asia-Pacific region.

The major players in the global hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Corporation (Japan), and NxStage Medical, Inc. (U.S.).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...